Cefprozil is a second-generation cephalosporin antibiotic belonging to the β-lactam class of drugs. It acts by inhibiting bacterial cell wall synthesis, leading to bacterial cell death. Cefprozil has good activity against both gram-positive and gram-negative bacteria. It is commonly administered orally, which makes it convenient for outpatient treatment. The drug is widely used in the management of respiratory tract infections. Cefprozil is effective in treating otitis media, sinusitis, and pharyngitis. It is also used for skin and soft tissue infections caused by susceptible organisms. Cefprozil shows stability against certain β-lactamases, enhancing its effectiveness. It is generally well tolerated with a favorable safety profile. Overall, cefprozil is an important antibiotic for treating mild to moderate bacterial infections.
